Portfolio company
Rapidscan
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops biopharmaceutical stress agents used for cardiovascular disease diagnosis in healthcare settings.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Ischemia Technologies
This company develops and manufactures in vitro diagnostic products for cardiovascular and acute care medicine to assist clinicians in detecting cardiac ischemia.
EP Solutions SA
This company develops non-invasive cardiac mapping technology to assist physicians in diagnosing rhythm disturbances and improving outcomes for heart failure patients.
CAD TREATMENT OPTIMIZATION
This medical technology company develops advanced intravascular imaging systems to help cardiologists assess and treat coronary artery disease in patients.
ACS Biomarker
This company provides biomarker discovery and validation services for cardiovascular disease diagnostics to academic research groups and pharmaceutical industry partners.
Alzeca Biosciences
This company develops MRI contrast agents to enable early diagnosis of Alzheimer's disease and other neurodegenerative disorders for healthcare providers and clinical researchers.
CV Therapeutics
This biopharmaceutical company develops and commercialises small molecule drugs for patients with cardiovascular diseases, including chronic angina and myocardial perfusion imaging needs.
Upfront Diagnostics
The company develops rapid point-of-care blood tests for stroke identification, serving paramedics, emergency medical services, and hospital clinicians.
ROTOP
This company manufactures radiopharmaceuticals and cold kits for diagnostic imaging and cancer therapy, serving hospitals, clinics, and pharmaceutical research partners globally.
